位置:首页 > 产品库 > 重组T-细胞急性淋巴细胞白血病蛋白1(TAL1)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
重组T-细胞急性淋巴细胞白血病蛋白1(TAL1)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。

重组T细胞急性淋巴细胞白血病蛋白1
Recombinant TAL1
基因名:

TAL1


产品别名:

SCL; TCL5; bHLHa17; tal-1; TAL1; TAL bHLH transcription factor 1, erythroid differentiation factor; TAL bHLH transcription factor 1, erythroid differentiation factor; T-cell acute lymphocytic leukemia protein 1; T-cell acute lymphocytic leukemia 1; T-cell leukemia/lymphoma protein 5; class A basic helix-loop-helix protein 17; stem cell protein; tal-1 product; T-细胞急性淋巴细胞白血病蛋白1(TAL1); T细胞急性淋巴细胞白血病蛋白1;


背景信息:
Activation of TAL1 characterizes up to 60% of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase IIalpha, a serine/ threonine protein kinase known to modulate the activity of other bHLH transcription factors.
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025